Steven C Plaxe Selected Research

Anti-Bacterial Agents (Antibiotics)

2/2017	Diagnosis and treatment of Clostridium difficile (C. diff) colitis: Review of the literature and a perspective in gynecologic oncology.
11/2013	Excess risk of Clostridium difficile infection in ovarian cancer is related to exposure to broad-spectrum antibiotics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steven C Plaxe Research Topics

Disease

16	Neoplasms (Cancer) 01/2022 - 01/2002
6	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2002
5	Carcinoma (Carcinomatosis) 01/2020 - 11/2008
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2020 - 11/2008
2	Endometrial Neoplasms (Endometrial Cancer) 01/2019 - 02/2002
2	Lung Neoplasms (Lung Cancer) 01/2018 - 12/2017
2	Obesity 09/2015 - 04/2014
2	Fatigue 08/2015 - 11/2014
1	Monoclonal Gammopathy of Undetermined Significance 01/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 09/2020
1	Crohn Disease (Crohn's Disease) 09/2020
1	Multiple Myeloma 12/2019
1	Glioblastoma (Glioblastoma Multiforme) 12/2019
1	Acquired Immunodeficiency Syndrome (AIDS) 10/2019
1	Kaposi Sarcoma (Kaposi's Sarcoma) 10/2019
1	Merkel Cell Carcinoma 01/2019
1	Vitiligo 12/2017
1	Kidney Neoplasms (Kidney Cancer) 12/2017
1	Melanoma (Melanoma, Malignant) 12/2017
1	Pruritus (Itching) 12/2017
1	Infections 02/2017
1	Adenocarcinoma 01/2017
1	Renal Insufficiency (Renal Failure) 09/2015
1	Hypertension (High Blood Pressure) 09/2015
1	Heart Failure 09/2015
1	Fever (Fevers) 11/2014
1	Nausea 11/2014
1	Ascites 11/2014
1	Vomiting 11/2014
1	Abdominal Pain (Pain, Abdominal) 11/2014
1	Chills 11/2014
1	Ovarian Epithelial Carcinoma 02/2014
1	Overweight 12/2013
1	Uterine Neoplasms (Uterine Cancer) 12/2013
1	Clostridium Infections 11/2013
1	Neutropenia 08/2002
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2002

Drug/Important Bio-Agent (IBA)

4	PlatinumIBA 01/2022 - 01/2002
4	NSC 366140 (pyrazoloacridine)IBA 08/2002 - 01/2002
2	Immune Checkpoint InhibitorsIBA 07/2021 - 09/2020
2	RNA (Ribonucleic Acid)IBA 10/2020 - 01/2002
2	NivolumabIBA 09/2020 - 12/2017
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 11/2008
2	Anti-Bacterial Agents (Antibiotics)IBA 02/2017 - 11/2013
1	Immunoglobulin M (IgM)IBA 01/2022
1	adavosertibIBA 01/2022
1	Sodium Glutamate (Accent)IBA 07/2021
1	Biomarkers (Surrogate Marker)IBA 10/2020
1	Pharmaceutical PreparationsIBA 09/2020
1	pembrolizumabIBA 09/2020
1	Gemcitabine FDA Link 01/2020
1	carfilzomibIBA 12/2019
1	avelumabIBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2018
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2018
1	LigandsIBA 12/2017
1	Programmed Cell Death 1 ReceptorIBA 12/2017
1	ORALIT (ORS)IBA 09/2015
1	CytokinesIBA 11/2014
1	catumaxomabIBA 11/2014
1	Antineoplastic Agents (Antineoplastics)IBA 11/2013
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 06/2013
1	Tyrosine (L-Tyrosine)FDA Link 06/2013
1	Focal Adhesion Protein-Tyrosine KinasesIBA 06/2013
1	Messenger RNA (mRNA)IBA 06/2013
1	Biological ProductsIBA 04/2008
1	DNA (Deoxyribonucleic Acid)IBA 01/2002
1	AcridinesIBA 01/2002
1	9-methoxyacridineIBA 01/2002

Therapy/Procedure

8	Drug Therapy (Chemotherapy) 01/2022 - 01/2002
7	Therapeutics 01/2022 - 01/2018
3	Radiotherapy 01/2020 - 09/2015
2	Hysterectomy 01/2017 - 12/2013
1	Intravenous Infusions 09/2020
1	Adjuvant Chemotherapy 12/2019
1	Chemoradiotherapy 12/2019
1	Immunotherapy 01/2019
1	Urinary Diversion (Ileal Conduit) 01/2016
1	Brachytherapy 09/2015
1	Terminal Care (Care, Terminal) 08/2015
1	Punctures 11/2014
1	Bariatric Surgery 04/2014
1	Lymph Node Excision (Lymph Node Dissection) 02/2014
1	Duration of Therapy 11/2013
1	Combination Drug Therapy (Combination Chemotherapy) 11/2008
1	Drug Tapering 08/2002